BioSpace News Archive

Progressive Care Inc., a personalized healthcare services and technology company, is pleased to announce its new partnership with DeliverSTAT, a provider of an all-in-one pharmacy delivery logistics solution.

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of Federico Bolognani, M.D., Ph.D. to the newly-created position of Vice President and Head of Clinical Science, effective November 2, 2020.

OPTEC International, Inc announced that the Company now has a suite of air purification products that effectively kills 99.99% of virus, bacteria, germs, and other harmful contaminants based on SGS testing.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has achieved a number of significant milestones over the past several weeks for Mino-Lok®.

obp, the leading global developer of single-use, self-contained, illuminating medical devices, today announced the launch of ONETRAC LXD, a single-use, cordless dual-blade surgical retractor with integrated multi-LED light source and dual smoke evacuation channels and ONETRAC LXS, a single-use suction device with integrated, cordless radial LED light source.

Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it has recently commenced phase III clinical trials for its inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences (Sinovac LS), or “CoronaVac,” in Turkey. T

Genetics Research, LLC (“GR”), a privately-held company developing a portfolio of novel and proprietary CRISPR-associated technologies for targeted DNA enrichment, announced today that it has licensed certain of its patents relating to this technology to Oxford Nanopore Technologies, Ltd. (“Oxford Nanopore”) based in Oxford, United Kingdom.

Instrumentation Laboratory (IL) announced today that the US Food and Drug Administration (FDA) granted De Novo marketing authorization for the HemosIL® Liquid Anti-Xa test kit to measure apixaban.

Neogen Corporation announced that revenues for the first quarter of its 2021 fiscal year, which ended Aug. 31, were $109,325,000, an 8% increase compared to the previous year’s first quarter revenues of $101,424,000.

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the United States Patent and Trademark Office (USPTO) has issued the Company a new Notice of Allowance for a patent (Application No. 15/748,784) on anti-neoplastic compounds and methods targeting Quiescin Sulfhydryl Oxidase 1 (QSOX1), an enzyme impor